Oregano

Oregano (Origanum vulgare L.): A Comprehensive Reference

1. Identity and Botanical Description

Botanical name: Origanum vulgare L. Family: Lamiaceae (the mint family). Common names: oregano, wild marjoram, Spanish marjoram.

Origanum vulgare L. is probably the best-known species of the genus Origanum and has uses in traditional medicine and as a culinary spice. The name Origanum was first used by Hippocrates (460–370 BC), comes from the Greek words for mountain (oros) and joy (ganos), and can be translated as "joy of the mountains."

It is a woody, perennial, and very tough plant with a straight stem, petiolate and ovate leaves, and white, pink, or light purple flowers. It is native throughout the Mediterranean region, in most parts of the Euro-Siberian region, and in the Irano-Turanian region. O. vulgare is a perennial plant growing to more than 100 cm, forming an erect, top-branching stem, sometimes reddish in color.

The genus Origanum (Lamiaceae) is divided into ten sections comprising 43 species, 6 subspecies, 3 cultivars, and 18 natural hybrids, including annuals, perennials, and shrubs, which are commonly found in the Mediterranean, Euro–Siberian, and Iranian–Siberian regions. Most species in the genus (about 75%) are found in the western Mediterranean area, with 16 considered endemic to Turkey.

Based on the recent classification of the World Flora Online, five different subspecies have been reported for O. vulgare: subsp. glandulosum, subsp. gracile, subsp. hirtum, subsp. virens, and subsp. vulgare. Now grown and cultivated on most continents under a variety of conditions — which can affect the specific constituents of its essential oils — Greece, Israel, and Turkey are known for producing high-quality oregano essential oils.

Common Forms and Preparations

• Dried culinary herb: Oregano leaves are used dry or fresh as a culinary herb to flavor pizza, fish, meat, vegetables, and baked goods.
• Essential oil (EO): Obtained by steam distillation of the aerial parts; used as a dietary supplement in liquid or encapsulated form.
• Capsules (softgels): Each softgel typically contains 140 to 200 mg of oil standardized to 60% to 80% carvacrol, the phenolic compound responsible for most antimicrobial and anti-inflammatory effects documented in published studies.
• Tincture: A tincture (1:5, 45%) is taken as 2–3 ml in a little water up to twice a day.
• Herbal infusion (tea): To make an infusion, 1 teaspoon of dried material is placed in one cup of boiling water and infused for 10–15 minutes, to be drunk hot up to 3 times a day.
• Topical preparations: Oregano may be used as an ointment or nasal spray to treat irritated skin around the nostrils.
• Steam inhalation: Boiling water can be poured over the fresh or dry herb, or the essential oil, for topical application or for use as a steam inhalation.

2. Traditional and Historical Use

Oregano's documented use spans more than 2,500 years across Mediterranean, Middle Eastern, and Asian cultures. Even before the Greeks fully documented its benefits, it is recorded that oregano was being used by the Assyrians as early as 3000 BC.

Ancient Greece and Rome

Medicinal uses for oregano date back to the ancient Greek and Roman empires, where applications of the leaves were used to treat skin sores, to relieve aching muscles, and as an antiseptic. The Greek physician Hippocrates (460–370 BC) used oregano not only for antiseptic purposes but also to protect against respiratory ailments and gastrointestinal distress.

The ancient Greeks and Romans used the leaves as an antiseptic and for treating skin sores, aching muscles, stomach aches, coughs, colds, and other respiratory diseases, and oregano tea with wine for treating snake bites. Oregano's essential oils were used to stimulate or increase menstrual flow (as an emmenagogue), to induce perspiration (as a diaphoretic), and, added to a liquid or lotion (liniment) for rubbing on the body, to relieve pain.

The Greeks employed oregano in marriage ceremonies to provide joy and in funeral services to provide peace to the departed. Oregano appears in the earliest written traces of Greek medicine — the writings attributed to Hippocrates (5th/4th cent. BC).

Medieval Europe

Medieval Europeans would chew on oregano leaves to alleviate rheumatism, toothache, indigestion, and cough. Oregano does not appear in the Qanun of medicine by Ibn Sina (980–1037), who generally followed Greek medicine with great accuracy. In the West, however, oregano can be found in the Old-English Herbal, possibly dating back to the same period.

East Asia and Other Cultures

During the Middle Ages, oregano made the journey to China, where it was also used for medicinal purposes. The Chinese believed it helped with fever, vomiting, and upset stomach.

Oregano has also been used in traditional medicines for such ailments as asthma, cramping, diarrhea, and indigestion.

3. Key Constituents and Active Compounds

Essential Oil Components

Essential oils obtained from Origanum vulgare are formed by a complex mixture of terpenes. Based on their proportions of cymyl, acyclic linalool/linalyl acetate, and sabinyl compounds, three major chemotypes have been identified. Within this complex chemical mixture, the two structurally similar cymyl compounds — carvacrol and thymol — are recognized as the main ones responsible for most of the biological activities of oregano EOs, and in particular, most of their antimicrobial activities.

Over 60 different compounds have been identified, with the primary ones being thymol and carvacrol. Further components are p-cymene, caryophyllene, spathulenol, germacrene-D, fenchyl alcohol and terpineol, terpinene, pinene, and limonene.

The essential oil content is often variable depending on the climatic conditions of plant growth.

Polyphenols and Non-Volatile Compounds

In addition to essential oil, oregano is a rich source of polyphenols, especially flavonoids (e.g., luteolin, apigenin, and quercetin derivatives) and phenolic acids (particularly rosmarinic acid).

Oregano contains a large amount of triterpene phenolic acids including rosmarinic, ursolic, oleanolic, caffeic, and lithospermic acids, as well as unique constituents known as origanol A and origanol B. Other bioactive secondary metabolites with prominent effects include β-caryophyllene oxide, β-sitosterol, and flavonoids: eriocitrin, apigenin, luteolin, chrysoeriol, diosmetin, quercetin, and eriodictyol.

The aerial parts of oregano contain a wide array of chemical constituents, including phenolics, terpenes, flavonoids, glucosides, sterols, tannins, resins, and mucilages.

Mechanisms of Action

Antimicrobial: Oregano is particularly rich in compounds like thymol, carvacrol, and β-caryophyllene, which contribute to its potent antibacterial effects. These include disruption of bacterial cell membranes, interference with quorum sensing, and inhibition of biofilm formation. Oregano EO has shown effectiveness against both antibiotic-resistant and non-resistant bacterial strains, such as Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. The components of this EO disrupt membrane integrity, ion transport, membrane surface charge, biofilm formation, and other biophysical parameters, eventually leading to cell death.

These compounds primarily target bacterial cell membranes, increasing their permeability and leading to the loss of essential intracellular components, ultimately causing cell death. Additionally, by inhibiting key bacterial enzymes such as ATPases, essential oils disrupt bacterial energy metabolism and impair survival. Their ability to interfere with quorum sensing and biofilm formation enhances antimicrobial efficacy, especially against resistant bacterial strains like Pseudomonas aeruginosa and Staphylococcus aureus.

When a wide range of concentrations were tested for carvacrol, thymol, and oregano essential oil, as well as for carvacrol–thymol mixtures, it was found that mixtures of carvacrol and thymol gave an additive effect, and that the overall inhibition by oregano EO can be attributed mainly to the additive antimicrobial action of these two compounds.

Anti-inflammatory: The anti-inflammatory activity of these compounds is also highlighted, with emphasis on their modulation of key signaling pathways such as nuclear factor-kappa B (NF-κB) and mitogen-activated protein kinases (MAPKs), and their ability to downregulate pro-inflammatory cytokines.

Molecular docking confirmed that thymol and carvacrol in oregano essential oil had good binding ability to core targets including TNF, IL-6, MyD88, and ALB, indicating that thymol and carvacrol have good anti-inflammatory effects.

Antioxidant: The antioxidant potential of oregano, evaluated by DPPH, ABTS, and H₂O₂ scavenging assays, demonstrated significant activity in both leaf and rhizome extracts. The free hydroxyl group in carvacrol's structure is considered central to its radical-scavenging capacity.

Anti-inflammatory (rosmarinic acid pathway): Rosmarinic acid (RosA) is a water-soluble phenolic compound that is an ester of caffeic acid and 3,4-dihydroxyphenyl lactic acid, discovered in many plants of the Boraginaceae and Lamiaceae families. RosA has a wide range of pharmacological effects, including anti-oxidative, anti-apoptotic, anti-tumorigenic, and anti-inflammatory effects. The anti-inflammatory effects of RosA have been revealed through in vitro and in vivo studies of various inflammatory diseases like arthritis, colitis, and atopic dermatitis.

4. Scientific Evidence by Area of Use

4.1 Antimicrobial Activity

In vitro and preclinical evidence (strong body of laboratory data):

The potential of oregano EO as a protective agent in human chronic degenerative and infectious diseases, suggested by its several biological activities such as antimicrobial, antifungal, antiparasitic, anti-inflammatory, anticancer, and antiproliferative, has prompted a host of studies related to its potential pharmaceutical applications. Research highlights its potential in combatting antibiotic resistance, either alone or in synergy with traditional antibiotics.

Thymol has shown efficacy against Salmonella, Bacillus cereus, and Helicobacter pylori, targeting their enzymatic pathways and preventing bacterial proliferation. Antimicrobial testing confirmed inhibitory effects against Staphylococcus aureus (MSSA and MRSA), Proteus mirabilis, and Enterococcus faecalis.

Human/clinical evidence (limited):

Oregano has antimicrobial, antifungal, antiparasitic, antioxidant, and antineoplastic activities in vitro and in vivo, but these effects have not been demonstrated in humans, and the clinical significance of these actions has not been established. It is a long way from killing microorganisms in a test tube or on the surface of a block of cheese to medicinal effects in the body. Only double-blind, placebo-controlled studies in humans can prove a treatment effective, and none have been performed on oregano oil for most of these purposes.

A 2023 study found that supplementation with oregano oil reduced the symptoms and improved the quality of life for patients with chronic rhinosinusitis. A 2019 study found that when added to mouthwash, oregano oil reduced plaque and gingivitis.

Evidence strength: Very strong in vitro and antimicrobial laboratory evidence. Clinical evidence in humans is preliminary and sparse, with no large randomized controlled trials completed for most infectious indications as of the time of this writing.

4.2 Antifungal Activity

In vitro evidence: Studies evaluated the in vitro activity of essential oil extracted from Origanum vulgare against sixteen Candida species isolates. The antifungal activity of oregano essential oil against species of Aspergillus such as A. parasiticus, A. niger, A. flavus, and A. ochraceus was demonstrated in studies where it was shown to inhibit growth and aflatoxin production. The effects of oregano essential oil on yeasts of medical importance such as Candida albicans isolated from human patients have also been studied.

Some monoterpenes and sesquiterpenes may be responsible for the susceptibility of the isolates tested to oregano essential oil, since the antifungal activity of this oil has been attributed to thymol, carvacrol, and eugenol.

Evidence strength: Antifungal activity is well-documented in vitro. Human clinical trials specifically for fungal infections are lacking.

4.3 Antiparasitic Activity

Human pilot study (limited): In human trials, orally given emulsified oregano oil has shown high activity against intestinal parasites Blastocystis hominis, Entamoeba hartmanni, and Endolimax nana. The Force et al. (2000) study — described as a small pilot — enrolled 14 adults who had tested positive for intestinal parasites. After 6 weeks of oregano oil at 600 mg/day, 8 of 11 patients (73%) showed complete clearance of Blastocystis, while Entamoeba showed partial reduction. The evidence gap is significant: no randomized controlled trial in humans has confirmed oregano oil's antiparasitic efficacy. The Force et al. pilot lacked a placebo group, and the sample was too small for firm conclusions.

Evidence strength: Preliminary. One small, uncontrolled human pilot study; no placebo-controlled RCTs.

4.4 Antioxidant Activity

Laboratory and in vivo evidence (substantial):

Oregano essential oil, rich in thymol and carvacrol, has a number of health-promoting properties. These compounds exhibit significant antioxidant, anti-inflammatory, antiangiogenic, and anticancer activities.

A large number of pharmacological studies have been carried out to demonstrate the various biological activities of rosmarinic acid, including anti-inflammation, anti-oxidation, anti-diabetes, anti-virus, anti-tumor, neuroprotection, and hepatoprotection. In a 2024 systematic review (PRISMA-compliant, based on 25 studies), rosmarinic acid, a polyphenolic compound found in herbs including those of the Lamiaceae family, has garnered significant attention due to its potent antioxidant and anticancer properties. The review examined the molecular mechanisms underlying these properties and their potential application in cancer prevention and therapy.

Evidence strength: Strong preclinical (in vitro and animal) evidence for antioxidant activity. Human intervention trials specifically assessing oregano's antioxidant effects in vivo remain limited.

4.5 Anti-inflammatory Activity

Cell and tissue models: Findings along with existing studies largely support the anti-inflammatory, tissue remodeling, immunomodulatory, and anticancer activities of oregano EO. One study provided the first evidence of the biological activity of oregano EO in human dermal fibroblasts, suggesting that OEO, with carvacrol as the major active component, is a promising candidate for use in skin care products with anti-inflammatory and anticancer properties.

Oregano EO significantly inhibited tissue remodeling biomarkers including collagen I, collagen III, EGFR, MMP-1, PAI-1, TIMP-1, and TIMP-2. An immunomodulatory biomarker, macrophage colony-stimulating factor (M-CSF), was also strongly inhibited by OEO treatment. In addition, OEO significantly modulated global gene expression and altered signaling pathways, many of which are critical in inflammation, tissue remodeling, and cancer signaling processes.

Evidence strength: Well-characterized mechanistically in cell culture and some animal models. Large randomized human trials on anti-inflammatory endpoints are not yet available.

4.6 Anticancer Activity

In vitro evidence only: The essential oils present in Origanum vulgare are a valid source of biologically active compounds endowed with antibacterial, antifungal, antioxidant, anti-inflammatory, and antilipogenic properties. An anticancer effect of oregano EO has been demonstrated on stomach cancer, breast adenocarcinoma, cervical adenocarcinoma, and colon adenocarcinoma cell lines.

The anticancer activity of carvacrol and rosmarinic acid (RA) from oregano was evaluated on human glioblastoma (U87) and triple-negative breast cancer (MDA-MB231) cell lines in vitro. RA anticancer activity was negligible in this assay. Carvacrol and the extracts were about 1.5–2 times more active against the MDA-MB231 cell line compared to the U87 cell line.

Evidence strength: All current anticancer evidence is preclinical (in vitro and some animal models only). No human clinical trials have been conducted on oregano or its constituents as cancer treatments.

4.7 Metabolic Effects (Antidiabetic, Anti-Obesity)

Animal and cell culture models: Administration of the aqueous extract of Origanum vulgare to streptozotocin (STZ)-induced diabetic rats caused a significant reduction in blood glucose levels. Oregano exhibits antioxidant activity both in vitro and in vivo, and polyphenols and terpenes are known for their ability to improve insulin responsiveness. A study found that oregano EO counteracted palmitic acid-induced downregulation of IRS-1, AKT, and AS160 activation, as well as glucose uptake, in human adipocytes.

After establishing potent in vitro antioxidant activity, methanolic oregano extract (MOE) and aqueous oregano extract (AOE) were administered to mice with induced type 1 diabetes. While prophylactic AOE therapy had no impact on diabetes induction, MOE reduced diabetes incidence and preserved normal insulin secretion.

Evidence strength: Preclinical (in vitro and animal) only. No human clinical trials have confirmed antidiabetic or anti-obesity efficacy for oregano supplements.

4.8 Respiratory Health

Oregano can be used fresh or dried and drunk as an infusion (tea) for simple conditions in the digestive and respiratory systems, as well as to treat minor infections. It is considered tonic to the lungs and has a specific affinity for conditions in the upper respiratory tract.

The 2023 clinical study cited by EBSCO Research found that supplementation with oregano oil reduced symptoms and improved quality of life for patients with chronic rhinosinusitis. Scientific evidence has begun to emerge confirming some therapeutic uses for oregano oil, including this finding for chronic rhinosinusitis. The available evidence for respiratory indications remains limited to small studies.

Evidence strength: Traditional use is well-documented. Modern clinical evidence is emerging but limited to small, preliminary human studies.

4.9 Oral Health

A 2019 study found that when added to mouthwash, oregano oil reduced plaque and gingivitis. This represents one of the few areas where a human clinical application has been directly tested, though larger confirmatory trials are needed.

Evidence strength: Preliminary positive finding in one human study; more evidence is needed.

4.10 Hepatoprotective Activity

The hepatoprotective effect of O. vulgare extract on CCl₄-induced hepatotoxicity was evaluated in rats. Liver injury was estimated by determination of ALT, AST, GGT, total protein, albumin, GPx, catalase, SOD, and malondialdehyde. These values were improved by the administration of oregano extract, with a specific phenolic profile evidenced, with large amounts of rosmarinic and chlorogenic acids.

Evidence strength: Animal study only. No controlled human hepatoprotective trials are available.

5. Body Systems and Health Areas Associated with Oregano

• Immune and antimicrobial system: Broad-spectrum antibacterial, antifungal, and antiparasitic actions in vitro; emerging human evidence for rhinosinusitis and oral infection.
• Digestive system: Traditional and limited clinical use for indigestion, diarrhea, nausea, and intestinal parasites.
• Respiratory system: Traditional use as an expectorant and antispasmodic; early clinical signal for rhinosinusitis.
• Integumentary (skin) system: Anti-inflammatory and tissue-remodeling effects in human dermal fibroblast models; topical application for skin sores.
• Endocrine/metabolic system: Preclinical (animal/cell) evidence for effects on blood glucose and insulin signaling.
• Hepatic system: Hepatoprotective effects in animal models via antioxidant pathways.
• Oncological (preclinical only): In vitro cytotoxic effects on several cancer cell lines; no human data.

6. Dosage Forms and Dosages Reported in Studies

Oregano oil is available over-the-counter as a dietary supplement in multiple formulations including capsules and oil solutions. The typical recommended dose ranges widely based in part on the relative concentration of essential oils.

• Antiparasitic pilot study (Force et al., 2000): A pilot study enrolled 14 adults with confirmed intestinal parasites, who received oregano oil at 600 mg/day for 6 weeks.
• Capsules (general supplemental range): The typical dosage for oregano capsules ranges from 200 to 400 milligrams per day, divided into one to three doses.
• Soft-gel capsule (retail standard): Soft-gel capsules are typically dosed at around 600 milligrams a day, with each product having dosage recommendations depending on the size of the capsule.
• Infusion (tea): One teaspoon of dried material in one cup of boiling water, infused for 10–15 minutes, drunk hot up to 3 times a day.
• Tincture: A 1:5, 45% tincture at 2–3 ml in water, up to twice a day.

Culinary oregano is Generally Recognized as Safe (GRAS) by the FDA when used as a food flavoring and can be part of a balanced diet. Higher-dose preparations, however, are considered supplements and are not FDA-approved for treating or preventing disease.

7. Safety Considerations and Drug Interactions

General Tolerability

Oregano oil is usually well tolerated but side effects of higher doses can include abdominal discomfort, heartburn, constipation or diarrhea, nausea and vomiting, dizziness, and headache. Rare adverse events include hypersensitivity reactions.

Liver Safety

Oregano extracts have not been approved as therapy of any disease or condition but are available over-the-counter and are generally recognized as safe, have not been associated with serum enzyme elevations during therapy, and have not been implicated in cases of clinically apparent liver injury.

Pregnancy

Oregano in doses used as a dietary supplement is an abortifacient and should not be used during pregnancy. There is concern that taking oregano in amounts larger than food amounts might cause miscarriage.

Allergic Cross-Reactivity

Oregano can cause reactions in people allergic to Lamiaceae family plants, including basil, hyssop, lavender, marjoram, mint, and sage.

Bleeding Risk

Oregano might increase the risk of bleeding in people with bleeding disorders. Oregano might also increase the risk of bleeding in the context of surgery.

Blood Sugar

Oregano might lower blood sugar levels, meaning people with diabetes should use oregano supplements cautiously.

Drug Interactions

Challenges with oregano essential oil constituents persist, including cytotoxicity at high concentrations, chemical instability, poor water solubility, and variable pharmacokinetics.

Oregano enhances the risk of bleeding in individuals with bleeding disorders and can worsen the situation when a person is already on blood-clotting medications. There are also concerns about interactions with diabetes medications and potential CYP enzyme effects; note that these interaction risks are largely inferred from preclinical pharmacological data rather than confirmed in human pharmacokinetic trials.

References

• Bioactive Potential of Origanum vulgare Rhizomes: Phenolic Composition, Antioxidant, Antibacterial, and Cytotoxicity Profiles — PMC
• Natural diversity in phenolic components and antioxidant properties of oregano (Origanum vulgare L.) accessions — Scientific Reports
• Chemical Composition, Biological Activity, and Potential Uses of Oregano (Origanum vulgare L.) and Oregano Essential Oil — Pharmaceuticals (MDPI)
• Chemical Composition, Biological Activity, and Potential Uses of Oregano — PMC
• Chemical Composition and Biological Activities of Essential Oils from Origanum vulgare Genotypes — PMC
• Antioxidant, Antibacterial, and Cytotoxic Activities of the Ethanolic Origanum vulgare Extract — PMC
• A study of the minimum inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol — PubMed
• Antimicrobial activity and mechanisms of action of Origanum vulgare L. essential oil — AIMS Biophysics
• Lights and Shadows of Essential Oil-Derived Compounds: Antimicrobial and Anti-Inflammatory Properties of Eugenol, Thymol, Cinnamaldehyde, and Carvacrol — PMC
• Integration of Network Pharmacology and Molecular Docking to Analyse the Mechanism of Action of Oregano Essential Oil in the Treatment of Bovine Mastitis — PMC
• Oregano — LiverTox®, NCBI Bookshelf, NIH
• Anti-inflammatory, tissue remodeling, immunomodulatory, and anticancer activities of oregano (Origanum vulgare) essential oil in a human skin disease model — PMC
• In vitro activity of Origanum vulgare essential oil against Candida species — PMC
• Antiprotozoal Activity of Turkish Origanum onites Essential Oil and Its Components — PMC
• Cytotoxic Effect Induced by Sicilian Oregano Essential Oil in Human Breast Cancer Cells — PMC
• The Influence of Different Oregano Species on the Antioxidant Activity and Anticancer Activity of Carvacrol and Rosmarinic Acid — PMC
• The Role of Rosmarinic Acid in Cancer Prevention and Therapy — PMC
• A Review of the Anti-Inflammatory Effects of Rosmarinic Acid on Inflammatory Diseases — PMC
• A Comprehensive Review of Rosmarinic Acid: From Phytochemistry to Pharmacology — PMC
• Origanum vulgare ssp. vulgare: Chemical Composition and Biological Studies — PMC
• Methanolic extract of Origanum vulgare ameliorates type 1 diabetes — British Journal of Nutrition
• Origanum vulgare L. Essential Oil Mitigates Palmitic Acid-Induced Impairments in Insulin Signaling — Pharmaceuticals (MDPI)
• Metabolites of oregano seed and their anti-obesity effects on 3T3-L1 adipocytes — PMC
• Oregano — McCormick Science Institute
• Oregano — Roots of Medicine, University of Iowa
• Herbs in History: Oregano — American Herbal Products Association
• Oregano oil's therapeutic uses — EBSCO Research Starters
• Oregano (Origanum vulgare): Benefits, Uses, Safety — Herbal Reality
• Oregano: Health Benefits, Side Effects, Uses, Dose & Precautions — RxList